logo
Book a meeting
Artax Biopharma

Artax Biopharma

Biotechnology, 1 Broadway, Cambridge, Massachusetts, 02142, United States, 1-10 Employees

artaxbiopharma.com

  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is ARTAX BIOPHARMA

Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the ...

Read More

lock icon Get Full Access
map
  • 1 Broadway, Cambridge, Massachusetts, 02142, United States Headquarters: 1 Broadway, Cambridge, Massachusetts, 02142, United States
  • 2013 Date Founded: 2013
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from ARTAX BIOPHARMA

Artax Biopharma Org Chart and Mapping

Employees
Shannon Dwyer

Shannon Dwyer

Director of in Vitro Biology

See Full Org Chart arrow
email-formate-icon
View Email Formats for Artax Biopharma
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Artax Biopharma

Answer: Artax Biopharma's headquarters are located at 1 Broadway, Cambridge, Massachusetts, 02142, United States

Answer: Artax Biopharma's phone number is 61********

Answer: Artax Biopharma's official website is https://artaxbiopharma.com

Answer: Artax Biopharma's revenue is $1 Million to $5 Million

Answer: Artax Biopharma's SIC: 2834

Answer: Artax Biopharma has 1-10 employees

Answer: Artax Biopharma is in Biotechnology

Answer: Artax Biopharma contact info: Phone number: 61******** Website: https://artaxbiopharma.com

Answer: Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T-cell activation. Specific control over T-cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access